Search results
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 1 day agoThe French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 1 day ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 1 day agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital,...
Barrons.com· 1 day agoNovavax stock surged after the vaccine maker signs a $1.2 billion licensing deal with France’s...
Why Novavax Stock More Than Doubled Today | The Motley Fool
The Motley Fool· 1 day agoShares of Novavax (NVAX 98.66%) are up 12% as of midday Friday following the release of the...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 1 day agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) delivered earnings and revenue surprises of -0.96% and 7.30%, respectively, for the...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 1 day agoCash and Cash Equivalents: Ended the quarter with $480.59 million, down from $568.51 million at the end of the previous quarter. On May 10, 2024, Novavax Inc (NASDAQ:NVAX) ...